ERAS

13.6104.29%
JA

James A. Bristol

Lead Independent Director

Dr. James A. Bristol, also known as Jim, is Independent Chairman of the Board of Ernexa Therapeutics Inc. (formerly known as Eterna Therapeutics Inc.) from December 19, 2023. Dr. Bristol was Director of Ernexa Therapeutics Inc. (formerly known as Eterna Therapeutics Inc.) from November 2023 to December 19, 2023. Dr. Bristol is Member of Scientific Advisory Board of Sai Life Sciences Limited. Dr. Bristol is Scientific Advisor of Verdant Therapeutics Inc. Dr. Bristol is Member of Scientific Advisory Board of Inipharm, Inc. Dr. Bristol is Independent Director of Erasca, Inc. from June 2018 and serves as its Lead Independent Director since July 2023. Dr. Bristol joined the Erasca, Inc. in June 2018. Dr. Bristol is Senior Advisor of Frazier Life Sciences Management, LP. Dr. Bristol was Advisor of Frazier Management, L.L.C. from 2009. Dr. Bristol was Senior Advisor of Frazier Management, L.L.C. from 2013. Dr. Bristol joined the Frazier Management, L.L.C. in 2009. Dr. Bristol focused on Life Science. Dr. Bristol was Executive-in-Residence of Oxford Bioscience Partners. Dr. Bristol was Director of Ignyta, Inc. until February 08, 2018. Dr. Bristol was employed at Ignyta, Inc. from February 28, 2014 to February 08, 2018. Dr. Bristol was Independent Director of Deciphera Pharmaceuticals, Inc. from August 2023 to June 11, 2024. Dr. Bristol was Independent Chairman of Deciphera Pharmaceuticals, Inc. from February 2015 to August 2023. Dr. Bristol was employed at Deciphera Pharmaceuticals, Inc. from February 2007 to June 11, 2024. Dr. Bristol was Member of Scientific Advisory Board of Karus Therapeutics Limited. Dr. Bristol was Director of Cadent Therapeutics, Inc. Dr. Bristol was Chairman of Scientific Advisory Board of Aravive Biologics, Inc. Dr. Bristol has Ph.D. in Organic Chemistry from The University of New Hampshire, Durham in 1972, B.S. in Chemistry from Bates College in 1968.

Positions